Lindsey Marie Hartley - 07 May 2026 Form 4 Insider Report for Axogen, Inc. (AXGN)

Reporting relationship: CFO
Issuer ticker: AXGN
Reported as of: 07 May 2026
Net transaction value: -$45,897
SEC form: 4
Accepted by SEC: 08 May 2026, 16:06:46 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Marc Began, as attorney-in-fact for Lindsey Hartley

Key filing fact

Lindsey Marie Hartley filed Form 4 for Axogen, Inc. (AXGN) on 08 May 2026.

Key facts

This page summarizes Lindsey Marie Hartley's Form 4 filing for Axogen, Inc. (AXGN).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 May 2026, 16:06.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$45,897.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002068693 Primary reporting owner

Hartley Lindsey Marie

Relationship: CFO
Address: 13631 PROGRESS BLVD., SUITE 400, ALACHUA
Signature: /s/ Marc Began, as attorney-in-fact for Lindsey Hartley
Signature date: 08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXGN transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,500
Change %: +4.1%
Price: $8.20^*
Shares after: 63,234
Date: 07 May 2026
Ownership: Direct

AXGN transaction

Common Stock

Sale

Transaction value: $20,874
Shares: -478
Change %: -0.76%
Price: $43.67
Shares after: 62,756
Date: 07 May 2026
Ownership: Direct

AXGN transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,963
Change %: +4.7%
Price: $8.27^*
Shares after: 65,719
Date: 07 May 2026
Ownership: Direct

AXGN transaction

Common Stock

Sale

Transaction value: $25,023
Shares: -573
Change %: -0.87%
Price: $43.67
Shares after: 65,146
Date: 07 May 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXGN transaction Derivative

Employee Stock Option (right to purchase)

Options Exercise

Transaction value
Shares: -2,500
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,500
Exercise price: $8.20
Footnotes: F1

AXGN transaction Derivative

Employee Stock Option (right to purchase)

Options Exercise

Transaction value
Shares: -2,963
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 07 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,963
Exercise price: $8.27
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

All shares of Axogen, Inc. common stock underlying the employee stock option were fully vested on March 16, 2026.

Footnote F2

All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.